It's A Brand New Vaccine for das RSV!
WESH: Researchers on cusp of rolling out new vaccine for RSV.
Researchers are on the cusp [ "It's in the hole!" - DD ] of rolling out a new vaccine to combat the respiratory syncytial virus amid an increase in cases in recent months.
RSV has become the second leading cause of hospitalization, and tens of thousands of people a year die from it. Children under 2 and adults older than 60 are most at risk for serious disease, and a vaccine has been elusive -- until now.
"It will be a huge, huge breakthrough for us to have an RSV vaccine available," said Dr. James Campbell, professor of pediatrics and the University of Maryland School of Medicine. [ In case you missed it, a doctor says this breakthrough is, "huge. Huge." - DD]
Moderna released preliminary results of their vaccine for RSV that shows it's more than 80% effective at preventing serious disease in people older than 60. The company is preparing to submit the vaccine to the Food and Drug Administration for approval, which follows submissions from Pfizer and GlaxoSmithKline late last year. [ Oh, so 25-35 days ago? - DD ]
"The Pfizer vaccine, they also relayed results on giving that same vaccine to pregnant women, and then what happens is the antibodies the woman makes, gets passed through the placenta into the baby, and they showed very good protection in the first three months of life," Campbell said.
Clinical trials are underway on a vaccine for babies and young children, who are among the high-risk groups for developing complications and dying from RSV.
Any animal trials or is Pharma jumping to babies and young children as their primary lab rats now?
Pinching a cigarette with thumb and index finger, exhaling smoke, "Das vacczines vill continue to be administered until ze morale improvez!"
No comments:
Post a Comment